GovChime
Notice ID: 649cdc32e3ab4fd791566e2135050a49PresolicitationArchived

Modification to the A11 HERV-E TCR and T cell product to improve the therapeutic efficacy for ccRCC patients.

Archived on June 4, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
9:00 AM EDT
Posted
May 19, 2026
Notice type
Presolicitation
Set-aside
No Set aside used
NAICS
622110: General Medical and Surgical Hospitals
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH OLAO
Place of performance
Bethesda, Maryland, 20892
Last updated
Oct 30, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
75N98026Q00392
Notice ID
649cdc32e3ab4fd791566e2135050a49

Description

Attachment: Notice of Intent to Sole Source

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

FALZONE, MICHAEL L

Documents

Files (1)

  • Notice of Intent to Sole Source.pdf

    206 KBAdded in Presolicitation version 3Posted
    Download

Lifecycle

  1. 3
    Version 3PresolicitationArchivedCurrent

    Modification to the A11 HERV-E TCR and T cell product to improve the therapeutic efficacy for ccRCC patients.

    Notice 649cdc32e3ab4fd791566e2135050a49 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N98026Q00392

Archive Date

Jun 4, 2026

Office Address

BETHESDA, MD, 20892